Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
287 participants
INTERVENTIONAL
2020-01-15
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: The primary objective of this study is to assess whether in-home, intensive nutrition counseling during pregnancy, compared to standard antenatal care, could improve GWG among pregnant women in rural Bangladesh.
Methods: This prospective, two-arm, parallel group, equal allocation, open-label, community-based, cluster-randomized controlled trial will be conducted in the icddr,b service area of Matlab, a rural subdistrict of Bangladesh. Clusters will be randomly allocated 1:1 to the intervention arm in which pregnant women will receive monthly in-home, intensive nutrition counseling or the control arm in which pregnant women will receive standard antenatal care as offered by icddr,b and Govt. facilities. Fixed Site Clinics (FSCs) located at the homes of the community health research workers (CHRWs) will act as clusters. Of the 33 FSCs serving rural areas in the icddr,b service area, 20 will be selected randomly and listed. These 20 clinics will then be randomly allocated 1:1 to either an intervention or control group using a computer-generated random allocation sequence. To fulfil the required sample size, each selected CHRW will enroll 16 consecutive pregnancies. Required sample size is 16 women per cluster i.e. 160 women per arm. Eligible participants will be enrolled upon obtaining their consent by 13 and 6/7 weeks of gestation (first trimester) and followed up to 6 weeks postpartum. Trained health workers will visit the homes of the women in the intervention arm once a month and provide nutrition counseling to the women and her influential family members such as mothers, mothers-in-law and husbands. Both intention-to-treat and per-protocol analyses will be performed.
Outcome measures/variables: Proportion of women with inadequate rate of weight gain in the second and third trimester of pregnancy according to the US Institute of Medicine (IOM) 2009 guidelines is the primary outcome variable.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
cRCT to Improve Maternal Nutrition Service Delivery During ANC
NCT04559711
Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in Bangladesh
NCT02745249
Effect of Dietary Counseling During Pregnancy on Infant Birthweight in Mangochi , Malawi
NCT03136393
Improving Birth Outcomes in Bangladesh
NCT05855551
$100Kitchen and Low-birth-weight Study in Rural Bangladesh
NCT02923882
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
In this arm, pregnant women, along with their influential family members such as mothers, mothers-in-law, and husbands, will receive monthly in-home, intensive nutrition counseling during the prenatal period.
In-home, intensive nutrition counseling
* Individualized sessions will be conducted by trained health workers following a standard document (counseling booklet)
* The messages to be provided through the counseling will be contextualized
* Sessions will start from the early second trimester and repeat monthly until 36 weeks of gestation
* Counseling sessions will be conducted at the participant's place
* Sessions will involve influential family members such as the husband, mother-in-law, mother, and the household head along with the pregnant women
* Women will receive personalized feedback on their dietary intake pattern (dietary diversity) and the rate of weight gain in each session
* Sessions will be tailored according to each participant's need and progress
Control
Pregnant women in this arm will receive standard antenatal care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
In-home, intensive nutrition counseling
* Individualized sessions will be conducted by trained health workers following a standard document (counseling booklet)
* The messages to be provided through the counseling will be contextualized
* Sessions will start from the early second trimester and repeat monthly until 36 weeks of gestation
* Counseling sessions will be conducted at the participant's place
* Sessions will involve influential family members such as the husband, mother-in-law, mother, and the household head along with the pregnant women
* Women will receive personalized feedback on their dietary intake pattern (dietary diversity) and the rate of weight gain in each session
* Sessions will be tailored according to each participant's need and progress
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in the first trimester of pregnancy (before 14 weeks of gestation)
* BMI 16-24.99 kg/m\^2 measured on enrollment
* willing to participate in the study
Exclusion Criteria
* threatened abortion, persistent pervaginal bleeding, or cervical incompetence
* history of three or more consecutive abortions
* history of gestational diabetes, macrosomia, gestational hypertension, preeclampsia/eclampsia in a prior pregnancy
* chronic diseases, such as hypertension, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, chronic liver disease, pancreatic diseases, Crohn's disease, ulcerative colitis, diabetes mellitus, thyroid dysfunction, immunological diseases, malignancy or any other diseases which could impede compliance with the study protocol
* taking medications known to influence fetal growth, such as insulin, thyroid hormones, glucocorticoids
* known case of serious psychiatric or behavioral disorders, such as schizophrenia, bipolar disorder
* scored as moderate or worse on enrollment on any one of the subscales of the Depression, Anxiety and Stress Scales-21 (DASS-21)
* inability to read or write Bengali
* belonging to moderately or severely food insecure households as measured by the Household Food Insecurity Access Scale (HFIAS)
* having a plan to move or deliver outside the study area
* women practicing some form of vegetarianism
* women belonging to a household from which another woman is already enrolled in the study
18 Years
39 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Obstetrical and Gynaecological Society of Bangladesh (OGSB)
UNKNOWN
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
S. M. Tafsir Hasan, MBBS, MS
Role: PRINCIPAL_INVESTIGATOR
Nutrition and Clinical Services Division, icddr,b
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Centre for Diarrhoeal Disease Research, Bangladesh
Chāndpur, , Bangladesh
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR-19109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.